Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus-Reference-Cited by-同舟云学术

Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus

Published:2006-03 Issue:3 Volume:50 Page:1079-1082
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Cui Longzhu¹²,Tominaga Eiji²,Neoh Hui-min¹,Hiramatsu Keiichi¹²

Affiliation:

1. Department of Bacteriology

2. Department of Infection Control Science, Juntendo University, 2-1-1 Bunkyo-Ku, Tokyo, Japan 113-8421

Abstract

ABSTRACT We present here findings of a strong positive correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus (VISA). This correlation is related to cell wall thickening, suggesting that, similar to the case with vancomycin resistance in VISA, the physical barrier of a thickened cell wall may contribute to daptomycin resistance in S. aureus .

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.50.3.1079-1082.2006

Reference20 articles.

1. Bactericidal Activities of Two Daptomycin Regimens against Clinical Strains of Glycopeptide Intermediate-Resistant Staphylococcus aureus , Vancomycin-Resistant Enterococcus faecium , and Methicillin-Resistant Staphylococcus aureus Isolates in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations

2. In Vitro Activities of Daptomycin, Arbekacin, Vancomycin, and Gentamicin Alone and/or in Combination against Glycopeptide Intermediate-Resistant Staphylococcus aureus in an Infection Model

3. Alder, J. 2005. Daptomycin: a new drug class for the treatment of Gram-positive infections. Drugs Today (Barcelona)41:81-90.

4. Vancomycin-Resistant Enterococci

5. Daptomycin Dose-Effect Relationship against Resistant Gram-Positive Organisms

Cited by 378 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global distribution of heterogeneous vancomycin-intermediate Staphylococcus aureus strains (1997–2021): a systematic review and meta-analysis;Journal of Global Antimicrobial Resistance;2024-06

2. Combating Multidrug Resistance: The Potential of Antimicrobial Peptides and Biofilm Challenges;International Journal of Innovative Science and Research Technology (IJISRT);2024-04-18

3. Staphylococcus aureus response and adaptation to vancomycin;Advances in Microbial Physiology;2024

4. Resistance phenotype and genetic features of a heterogeneous vancomycin intermediate–resistant Staphylococcus aureus strain from an immunocompromised patient;Brazilian Journal of Microbiology;2023-12-07

5. The evolution of diverse antimicrobial responses in vancomycin-intermediateStaphylococcus aureusand its therapeutic implications;2023-12-01